Latest News
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports...
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
/CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine,...
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.
Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States...
Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built...
Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers.
June S&P 500 futures (ESM23) are up +0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.28% this morning as market participants continued to assess the path of Federal Reserve monetary policy following a solid U.S. jobs report while bracing for the start of the earnings season and inflation data later this week.
New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its...
Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting
/PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural...
Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee...
Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education...
Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND COMPASS™ Clinical Support App....
SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS
/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds...
Sunniva Inc. Announces Financial Update and Shareholder Update Call
VANCOUVER, BC , Oct. 20, 2021 /CNW/ - Sunniva Inc. ("Sunniva", the "Company") (CSE:SNN) (OTC Pink Sheets:SNNVF) announces an update regarding its financial condition and plan to host an update call for shareholders on Monday, October 25, 2021 .
Neurent Medical Expands Leadership Team to Support Advancement of In-Office Chronic Rhinitis Treatment
Neurent Medical , a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced expansions of its leadership team. The hires bring deep medical device industry and ear, nose and throat-specific experience...
Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity...
VANCOUVER, BC , June 17, 2020 /CNW/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF) announced that it has received notice from the British Columbia Securities Commission that the Company has been placed on the default issuers list as a result of the Company's failure to file its annual audited financial statements and accompanying management's discussion and analysis, and related CEO and CFO certifications, as required by National Instrument 52-109, for the financial year ended December 31, 2019 (the "Annual Filings") prior to the filing deadline on June 15, 2020 . Failure to correct the above noted deficiencies may result in further action including the issuance of a Cease Trade Order.